Systemic Pharmacokinetics of BOL-303224-A After Single and Multiple Instillations of BOL-303224-A in Subjects With Suspected Bacterial Conjunctivitis.

Trial Profile

Systemic Pharmacokinetics of BOL-303224-A After Single and Multiple Instillations of BOL-303224-A in Subjects With Suspected Bacterial Conjunctivitis.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Feb 2013

At a glance

  • Drugs Besifloxacin (Primary)
  • Indications Bacterial infections; Conjunctivitis
  • Focus Pharmacokinetics
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 30 Jun 2009 Actual patient number (24) added as reported by ClinicalTrials.gov.
    • 13 May 2008 Status changed from recruiting to completed on clinicaltrials.gov
    • 13 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top